Annexon, Inc. (ANNX) Financials
ANNX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 203.8 million | 47.0 million |
2023-06-30 | 233.0 million | 48.3 million |
2023-03-31 | 268.8 million | 53.9 million |
2022-12-31 | 285.1 million | 53.9 million |
ANNX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -28.3 million | 4.5 million |
2023-06-30 | -36.4 million | 4.7 million |
2023-03-31 | -33.1 million | 4.6 million |
2022-12-31 | -27.4 million | 4.8 million |
ANNX Net Income
No data available :(
ANNX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 165.3 million | - | 31.5 million |
2023-06-30 | 192.9 million | - | 32.0 million |
2023-03-31 | 228.2 million | - | 32.5 million |
2022-12-31 | 242.7 million | - | 32.9 million |
ANNX Shares Outstanding
ANNX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 19000 | 27.9 million | 6.9 million | - |
2023-06-30 | 30000 | 30.3 million | 7.0 million | - |
2023-03-31 | 137000 | 32.3 million | 8.9 million | - |
2022-12-31 | 282000 | 28.5 million | 8.2 million | - |
ANNX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 823000 |
2023-06-30 | - | 810000 |
2023-03-31 | - | 800000 |
2022-12-31 | - | 1.0 million |
ANNX
Price: $4.70
52 week price:
Earnings Per Share: -1.77 USD
P/E Ratio: -2.69
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 124730
Market Capitalization: 505.0 million